Yoshitsugu Kaku Selected Research

Yoshitsugu Kaku Research Topics

6	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 04/2005
2	Peritonitis 01/2022 - 06/2008
2	Proteinuria 01/2020 - 11/2018
1	Bronchitis 01/2022
1	Infections 01/2022
1	Hyponatremia 11/2021
1	Edema (Dropsy) 11/2021
1	Vasculitis (Vasculitides) 01/2020
1	Purpura 01/2020
1	Nephritis 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 11/2018
1	Sclerosis 11/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Dent Disease 01/2016
1	Hereditary Nephritis (Alport Syndrome) 11/2014

2	Immunoglobulin A (IgA)IBA 01/2020 - 11/2018
2	HLA-DR Antigens (HLA-DR)IBA 01/2020 - 01/2018
1	PlasticsIBA 01/2022
1	Human Serum Albumin FDA LinkGeneric 11/2021
1	DiureticsIBA 11/2021
1	Furosemide (Lasix)FDA LinkGeneric 11/2021
1	Tolvaptan FDA Link 11/2021
1	AntigensIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	mizoribineIBA 11/2018
1	Azathioprine (Imuran)FDA LinkGeneric 11/2018
1	CreatinineIBA 11/2018
1	Dipyridamole (Persantine)FDA LinkGeneric 11/2018
1	Heparin (Liquaemin)FDA LinkGeneric 11/2018
1	Prednisolone (Predate)FDA LinkGeneric 11/2018
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	Warfarin (Coumadin)FDA LinkGeneric 11/2018
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018
1	Chloride Channels (Chloride Channel)IBA 01/2016
1	Adenosine Triphosphatases (ATPase)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	RNA Splice SitesIBA 11/2014
1	Codon (Codons)IBA 11/2014
1	NucleotidesIBA 11/2014
1	nephrinIBA 04/2005
1	NPHS2 proteinIBA 04/2005

4	Therapeutics 11/2021 - 02/2015
2	Peritoneal Dialysis 01/2022 - 06/2008